Follow the Ypsomed Holding AG stock price and the full management transaction log of the company, a listed equity based in Switzerland. Shares are quoted on CH CH, under the supervision of SIX SER. Operating in the Health Care sector, Ypsomed Holding AG has published 14 public disclosures. Market capitalisation: €4.6bn. The latest transaction was reported on 6 July 2026 (Sale). Among the most active insiders: Anonymous (Executive member of the board of directors / member of senior management). All data is openly available.
14
Insider Decl.
0
Thresholds
€325,881
7 ops.
Buy Volume
€936,889
7 ops.
Sell Volume
26Σ signal
Buys €325,881€936,889 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 7,280 of 26,293 companies
62.6
score / 100
Value
45
Quality
80
FCF yld-0.4%
Earn yld4.8%
EV/EBITDA15.0x
ROE31%
Gross mgn43%
Net mgn30%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 July 2026
Declarations14 total
●
Anonymous (an executive member of the board of directors / member of senior management)
an executive member of the board of directors / member of senior management·Executives·(filed)
150 shares@ CHF 272.000.0009% mcap100.0% of flowSIX:T1N9T00027
14 of 14 declarations
About Ypsomed Holding AG
Ypsomed Holding AG is a Swiss company that specializes in the development and manufacturing of drug delivery systems, particularly injection devices. It focuses on solutions for diabetes and other chronic diseases.